<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02869750</url>
  </required_header>
  <id_info>
    <org_study_id>ADIPCOS</org_study_id>
    <nct_id>NCT02869750</nct_id>
  </id_info>
  <brief_title>Evaluation of Adipokines in Egyptian Women With Polycystic Ovary Syndrome</brief_title>
  <official_title>Evaluation of Adipokines ( Ghrelin, Resistin and Adiponectin), in Egyptian Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin),
      in obese and non-obese patients with polycystic ovary syndrome (PCOS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy selected PCOS patients will be recruited for this study, and will be divided into two
      groups based on their body mass index (BMI): 35 obese (BMIâ‰¥ 25 kg/m2, group A), 35 non-obese
      (BMI&lt;25 kg/m2, group B). In addition, 35 healthy non-obese women (BMI&lt;25 kg/m2) will bw
      enrolled as the control (group C). Serum levels of FSH (follicle stimulating hormone), LH
      (luteinizing hormone), T(testosterone), glucose, insulin, adiponectin, resistin and resistin
      will bw detected, and compared the differences of them among three groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum ghrelin level</measure>
    <time_frame>24 hours</time_frame>
    <description>measuring ghrelin, and ) in the three groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum resistin level</measure>
    <time_frame>24 hours</time_frame>
    <description>serum resistin level in the three groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum adiponectin level</measure>
    <time_frame>24 hours</time_frame>
    <description>serum adiponectin level in the three groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose/Insulin ratio</measure>
    <time_frame>24 hours</time_frame>
    <description>fasting glucose and insulin in three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum testosterone level</measure>
    <time_frame>24 hours after labor</time_frame>
    <description>serum testosterone level in three groups</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Polycystic Ovarian Syndrome</condition>
  <arm_group>
    <arm_group_label>Obese PCOS</arm_group_label>
    <description>PCOS patients with BMI more than 25 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean PCOS</arm_group_label>
    <description>PCOS patients with BMI less than 25 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCOS with normal HOMA2-1R</arm_group_label>
    <description>PCOS without Insuline resistance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCOS with elevated HOMA2-IR</arm_group_label>
    <description>PCOS with Insuline resistance</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      BLOOD SAMPLE
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Females with PCOS in child bearing age who presented at reproductive and endocrinology
        clinics at Ain Shams University Maternity Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females with PCOS in child bearing age who presented at reproductive and endocrinology
             clinics at Ain Shams University Maternity Hospital

        Exclusion Criteria:

          -  Known androgen secreting tumor.

          -  PCO on ovarian stimulation medications

          -  PCO with any other medical illness.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ahmed Kotb</name>
      <address>
        <city>Cairo</city>
        <state>Al Qahirah</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>February 25, 2018</last_update_submitted>
  <last_update_submitted_qc>February 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed El Kotb Abdel Fattah</investigator_full_name>
    <investigator_title>Lecturer in obstertics and gynecology, Ain Shams University Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

